Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: Are current harm reduction strategies working?

Journal of Infection

Volumn 40, Issue 2, 2000, Pages 176-183

  Taylor, A ^a   Goldberg, D ^a   Hutchinson, S ^a   Cameron, S ^b   Gore, S M ^c   McMenamin, J ^e   Green, S ^d   Pithie, A ^b   Fox, R ^b  

^a Scottish Centre for Infection and Environmental Health   (United Kingdom)

^b GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; FEMALE; HEPATITIS C; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; NEEDLE; PREVALENCE; SYRINGE; UNITED KINGDOM; VIREMIA;

EID: 0034107386     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1053/jinf.2000.0647     Document Type: Article

References (40)

1. Alter MJ, Hadler SC, Judson FN. Risk factors for acute non-A, non-B hepatitis in the United States and association with Hepatitis C virus infection. JAMA. 264:1990;22331-22335.
2. Wodak A, Crofts N. Once more into the breach: controlling hepatitis C in injecting drug users. Addiction. 91:1996;181-184.
3. Johnson AM, Wadsworth J, Wellings K, Field J. Sexual Attitudes and Lifestyles. 1994;Oxford Blackwell Scientific Publications.
4. Goldberg D, Cameron S, McMenamin J. Hepatitis C virus antibody prevalence among injecting drug users in Glasgow has fallen but remains high. Communicable Disease and Public Health. 1:1998;95-97.
5. Majid A, Holmes R, Desselberger U, Simmonds PO, McKee TA. Molecular epidemiology of hepatitis C virus infection amongst intravenous drug users in rural communities. J Med Virol. 46:1995;48-51.
6. Brind AM, Serfaty MA, Lawrie A. Hepatitis C virus (HCV) infection in a drug dependency centre in North-East England. Hepatology. 1996;1-42.
7. Lamden KH, Kennedy N, Beeching NJ. Hepatitis B and Hepatitis C virus infections: risk factors among drug users in Northwest England. J Infect. 37:1998;260-269.
8. Lam JPH, McOmish F, Burns SM, Yap PL, Mok JYQ, Simmonds P. Infrequent vertical transmission of hepatitis C virus. J Infect Dis. 167:1993;572-576.
9. Stimson G. AIDS and injecting drug use in the United Kingdom 1987-1993: the policy response and the prevention of theepidemic. Soc Sci Med. 41:1995;699-716.
10. Gruer L, Cameron J, Elliott L. Building a city wide service for exchanging needles and syringes. BMJ. 306:1993;1394-1397.
11. Frischer M, Leyland A, Cormack R. Estimating population prevalence of injected drug use and HIV infection among injecting drug users in Glasgow. Am J Epidemiol. 138:1993;170-181.
12. Frischer M, Bloor M, Green S. Reduction in needle sharing among community wide sample of injecting drug users. Int J STD and AIDS. 3:1992;288-290.
13. Goldberg D, Davis B, Allardice G, McMenamin J, Codere G. Monitoring the spread of HIV and AIDS in Scotland 1983-1994. Scottish Med J. 41:1996;131-138.
14. Bath GE, Burns S, Davies AG, Dominy N, Peters A, Richardson AM. HIV prevalence in injecting drug users in Edinburgh. Fewer drug users share needles. BMJ. 306:1993.
15. Taylor A, Frischer M, Green ST, Goldberg DJ, McKeganey N, Gruer L. Low and stable prevalence of HIV among Glasgow drug injectors. Int J STD and AIDS. 5:1994;105-107.
16. Brettle RP. HIV and harm reduction for injection drug users. AIDS. 5:1991;125-136.
17. Bulletin on Narcotics. XLV:1993;19-46.
18. Haw S, Frischer M, Donoghoe M. The importance of multi-site sampling in determining the prevalence of HIV among drug injectors in Glasgow and London. AIDS. 6:1992;517-518.
19. Frischer M, Goldberg D, Taylor A, Bloor M. Estimating the incidence and prevalence of injecting drug use in Glasgow. Addic Res. 5:1997;307-315.
20. Covell R, Follett E, Coote I. HIV testing among injecting drug users in Glasgow. J Infect. 26:1993;27-31.
21. Parry, J, Simple and reliable salivary tests for HIV and Hepatitis A and B virus diagnosis and surveillance, Ann New York Acad Sci, 216, 233.
22. Cameron S, Wilson K, Good T. Detection of antibodies against Hepatitis C virus in saliva: a marker of viral activity. J Viral Hep. 6:1999;141-144.
23. Gore, SM, Bird, AG, Cameron, SO, Hutchinson, SJ, Burns, SM, Goldberg, DJ, Prevalence of hepatitis C carriage in Scottish prisons: willing anonymous salivary hepatitis C (WASH-C) surveillance linked to self-reported risk behaviours, Quart J Med.
24. Data Analysis Products Division. S-Plus 4 Guide to Statistics. Seattle: MathSoft, 1997.
25. Gardner MJ, Altman DG. Statistics with confidence - confidence intervals and statistical guidelines. BMJ. 1989.
26. Millar AJ. Subset selection in regression Monographs on statistics and applied probability. 1990;Chapman and Hall, London.
27. Crofts N, Stewart T, Hearne P, Ping XY, Breschkin AM, Locarnini SA. Spread of blood-borne viruses among Australian prison entrants. BMJ. 310:1995;285-288.
28. Galeazzi B, Tufano A, Barbierato E, Bortolotti F. Hepatitis C virus infection in Italian intravenous drug users: epidemiological and clinical aspects. Liver. 15:1995;209-212.
29. Stark K, Schreier E, Muller R, Wirth D, Driesel G, Bienzle U. Prevalence and determinants of anti-HCV seropositivity and of HCV genotype among intravenous drug users in Berlin. Scand J Infect Dis. 27:1995;3313-3317.
30. Tenant F, Moll D. Seroprevalence of hepatitis A, B, C, and D markers and liver function abnormalities in intravenous heroin addicts. J Addict Dis. 14:1995;35-49.
31. Chewtwynbd J, Brunton C, Blank M, Plumridge E, Baldwin D. Hepatitis C seroprevalence amongst injecting drug usersattending a methadone programme. New Zeal Med J. 108:1995;364-366.
32. Shrestha SM, Shrestha DM, Gafney TE, Maharjan KG, Tsuda F, Okamoto H. Hepatitis B and C infection among drug abusers in Nepal. Trop Gasteroenterol. 17:1996;212-213.
33. Bolumar F, Hernandez-Aguado I, Ferrer L, Ruiz I, Avino MJ, Rebagliato M. Prevalence of antibodies to hepatitis C in a population of intravenous drug users in Valencia, Spain, 1990-1992. Int J Epidemiol. 25:1996;204-209.
34. De Carvalho HB, Mesquita F, Massad E. HIV and infections of similar transmission patterns in a drug injector community of Santos, Brazil. J Acquired Immune Deficiency Syndromes Hum Retrovirol. 12:1996;84-92.
35. Blair CS, Hayes PC. Hepatitis C: current concepts. Proceedings of the Royal College of Physicians Edinburgh. 27:1997;300-310.
36. Goldstein MF, Friedman SR, Neaigus A, Jose B, Ildefonso G, Curtis R. Self-reports of HIV risk behaviour by injecting drug users: are they reliable? Addiction. 90:1995;1097-1104.
37. Darke S. Self-report among injecting drug users: a review. Drug and Alcohol Dependence. 51:1998;253-263.
38. Crofts N, Jolley D, Kaldor J, van Beek I, Wodak A. Epidemiology of hepatitis C virus infection among injecting drug users in Australia. J Epidemiol Commun Health. 51:1997;692-697.
39. Coutinho RA. HIV and hepatitis C among injecting drug users. BMJ. 317:1998;424-425.
40. Frischer M, Elliott L, Taylor A. Do needle exchanges help to control the spread of HIV among injecting drug users. AIDS. 7:1993;1677-1678.